Role of Helicobacter pylori virulence factors and alteration of the Tumor Immune Microenvironment: challenges and opportunities for Cancer Immunotherapy-Reference-Cited by-同舟云学术

Role of Helicobacter pylori virulence factors and alteration of the Tumor Immune Microenvironment: challenges and opportunities for Cancer Immunotherapy

Published:2024-03-15 Issue:4 Volume:206 Page:
ISSN:0302-8933
Container-title:Archives of Microbiology
language:en
Short-container-title:Arch Microbiol

Author:

Zhou Junyi,Zhang Minna,Wang HongGang,Zhong Xiaomin,Yang XiaoZhong

Funder

Jiangsu Postgraduate Practice Innovation Program

Translational Medicine Innovative Talent Program, North Jiangsu Clinical Research Institute, Nanjing Medical University

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00203-024-03908-6.pdf

Reference102 articles.

1. Algood HM et al (2006) Helicobacter pylori persistence: an overview of interactions between H. Pylori and host immune defenses. Clin Microbiol Rev 19(4):597–613. https://doi.org/10.1128/CMR.00006-06

2. Amedei A et al (2006) The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses. J Clin Invest 116(4):1092–1101. https://doi.org/10.1172/JCI27177

3. Arai J et al (2024) Association between Vonoprazan and the risk of gastric cancer after Helicobacter pylori eradication. Clin Gastroenterol Hepatol. https://doi.org/10.1016/j.cgh.2024.01.037

4. Arnold IC et al (2018) Eosinophils suppress Th1 responses and restrict bacterially induced gastrointestinal inflammation. J Exp Med 215(8):2055–2072. https://doi.org/10.1084/jem.20172049

5. Bagchi S et al (2021) Immune Checkpoint inhibitors for the treatment of Cancer: clinical impact and mechanisms of response and resistance. Annu Rev Pathol 16:223–249. https://doi.org/10.1146/annurev-pathol-042020-042741